Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 1
2016 2
2017 2
2018 1
2019 6
2020 2
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer D, Imaz A, Lopez-Lirola A, Knobel H, Masiá M, Fanciulli C, Hernández C, Lagarde M, Gutierrez A, Curran A, Morano L, Montero-Alonso M, Troya J, Rigo R, Casadellà M, Navarro-Alcaraz A, Ardila F, Parera M, Bernal E, Echeverria P, Estrada V, Hidalgo-Tenorio C, Macias J, Prieto P, Portilla J, Valencia E, Vivancos MJ, Rivero A. Podzamczer D, et al. Among authors: lagarde m. J Antimicrob Chemother. 2023 Nov 6;78(11):2696-2701. doi: 10.1093/jac/dkad285. J Antimicrob Chemother. 2023. PMID: 37725999 Clinical Trial.
Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery.
Serrano-Villar S, Sanchez-Carrillo S, Talavera-Rodríguez A, Lelouvier B, Gutiérrez C, Vallejo A, Servant F, Bernadino JI, Estrada V, Madrid N, Gosalbes MJ, Bisbal O, de Lagarde M, Martínez-Sanz J, Ron R, Herrera S, Moreno S, Ferrer M. Serrano-Villar S, et al. Among authors: de lagarde m. J Infect Dis. 2021 Feb 13;223(3):471-481. doi: 10.1093/infdis/jiaa379. J Infect Dis. 2021. PMID: 32601702
Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients.
Valle-Millares D, Brochado-Kith Ó, Martín-Carbonero L, Domínguez-Domínguez L, Ryan P, De Los Santos I, De la Fuente S, Castro JM, Lagarde M, Cuevas G, Mayoral-Muñoz M, Matarranz M, Díez V, Gómez-Sanz A, Martínez-Román P, Crespo-Bermejo C, Palladino C, Muñoz-Muñoz M, Jiménez-Sousa MA, Resino S, Briz V, Fernández-Rodríguez A, On Behalf Of Multidisciplinary Group Of Viral Coinfection Hiv/Hepatitis Covihep. Valle-Millares D, et al. Among authors: lagarde m. Biomedicines. 2021 Nov 5;9(11):1627. doi: 10.3390/biomedicines9111627. Biomedicines. 2021. PMID: 34829855 Free PMC article.
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance.
De Miguel Buckley R, Rial-Crestelo D, Montejano R, Pinto A, Jimenez-Gonzalez M, Lagarde M, Esteban-Cantos A, Aranguren-Rivas P, Cadiñanos J, Bisbal O, Castro JM, Santacreu-Guerrero M, Bermejo-Plaza L, Moreno V, Hernando A, Martín-Carbonero L, Rubio R, Delgado R, Arribas JR, Pulido F; Antiretroviral Treatment Guided by Proviral Genotype (ART-PRO) Study Group. De Miguel Buckley R, et al. Among authors: lagarde m. Open Forum Infect Dis. 2022 Nov 8;9(11):ofac610. doi: 10.1093/ofid/ofac610. eCollection 2022 Nov. Open Forum Infect Dis. 2022. PMID: 36447613 Free PMC article.
Life expectancy of people with HIV on antiretroviral therapy in Spain.
Jarrín I, Rava M, Del Romero Raposo J, Rivero A, Del Romero Guerrero J, De Lagarde M, Martínez Sanz J, Navarro G, Dalmau D, Blanco JR, Koerting A, Gomez Castell J, Del Amo J; CoRIS. Jarrín I, et al. Among authors: de lagarde m. AIDS. 2024 Mar 1;38(3):387-395. doi: 10.1097/QAD.0000000000003772. Epub 2023 Oct 27. AIDS. 2024. PMID: 37905999
[Long-term safety and effectiveness of darunavir].
Rubio R, Matarranz M, Bisbal O, de Lagarde M, Domínguez L. Rubio R, et al. Among authors: de lagarde m. Enferm Infecc Microbiol Clin. 2016 May;34 Suppl 1:16-22. doi: 10.1016/S0213-005X(17)30004-6. Enferm Infecc Microbiol Clin. 2016. PMID: 28081758 Review. Spanish. No abstract available.
24 results